{"parse":{"title":"Olney's lesions","pageid":1443167,"revid":859902241,"text":{"*":"<div class=\"mw-parser-output\"><p><b>Olney's lesions</b>, also known as <b><a href=\"/wiki/NMDA_receptor_antagonist\" title=\"NMDA receptor antagonist\">NMDA receptor antagonist</a> neurotoxicity</b> (<b>NAN</b>), are a potential form of <a href=\"/wiki/Brain_damage\" title=\"Brain damage\">brain damage</a> due to drugs that have been studied experimentally and have produced neuronal damage, yet are administered by doctors to humans in the settings of <a href=\"/wiki/Pharmacotherapy\" title=\"Pharmacotherapy\">pharmacotherapy</a> and of <a href=\"/wiki/Anesthesia\" title=\"Anesthesia\">anesthesia</a>. They are named after <a href=\"/wiki/John_Olney\" title=\"John Olney\">John Olney</a>, who conducted a study in 1989 to investigate <a href=\"/wiki/Neurotoxicity\" title=\"Neurotoxicity\">neurotoxicity</a> caused by <a href=\"/wiki/Phencyclidine\" title=\"Phencyclidine\">PCP</a> and related drugs.<sup id=\"cite_ref-olney_1-0\" class=\"reference\"><a href=\"#cite_note-olney-1\">&#91;1&#93;</a></sup> They are important for two reasons. Firstly, <a href=\"/wiki/NMDA_receptor_antagonist\" title=\"NMDA receptor antagonist\">NMDA receptor antagonist</a> drugs are not only street drugs that are taken recreationally, they are also physician-prescribed drugs for therapeutic treatment of human diseases such as <a href=\"/wiki/Memantine\" title=\"Memantine\">memantine</a> for <a href=\"/wiki/Alzheimer%27s_disease\" title=\"Alzheimer&#39;s disease\">Alzheimer's disease</a> and <a href=\"/wiki/Amantadine\" title=\"Amantadine\">amantadine</a> for <a href=\"/wiki/Parkinson%27s_disease\" title=\"Parkinson&#39;s disease\">Parkinson's disease</a>. Secondly in the field of anesthesiology, the <a href=\"/wiki/Dissociative\" title=\"Dissociative\">dissociative</a> anesthesia of many general anesthetics is due to NMDA receptor antagonist properties. Because the neuronal vacuolation of Olney's lesions evolves into neuronal <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrosis</a> or death of neurons, it is important to determine whether Olney's lesions occur in humans, not only in experimental animals. The essential question is whether an <a href=\"/wiki/NMDA_receptor_antagonist\" title=\"NMDA receptor antagonist\">NMDA receptor antagonist</a> drug is to be considered a human <a href=\"/wiki/Neurotoxin\" title=\"Neurotoxin\">neurotoxin</a> or not. The <a href=\"/wiki/Patient_safety\" title=\"Patient safety\">patient safety</a> implications for <a href=\"/wiki/Pharmacotherapy\" title=\"Pharmacotherapy\">pharmacotherapy</a> and for <a href=\"/wiki/Anesthesia\" title=\"Anesthesia\">anesthesia</a> would each be profound, if the answer is affirmative. \n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Prevention\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Prevention</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Controversy\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Controversy</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Olney%27s_lesions&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In 1989, Olney et al. discovered that neuronal <a href=\"/wiki/Vacuolation\" class=\"mw-redirect\" title=\"Vacuolation\">vacuolation</a> and other cytotoxic changes (\"lesions\") occurred in brains of rats administered NMDA antagonists, including <a href=\"/wiki/Phencyclidine\" title=\"Phencyclidine\">PCP</a>, <a href=\"/wiki/MK-801\" class=\"mw-redirect\" title=\"MK-801\">MK-801</a> (dizocilpine) and <a href=\"/wiki/Ketamine\" title=\"Ketamine\">ketamine</a>.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>  Examination of neurons in the posterior cingulate and retrosplenial cortices by electron micrograph revealed apparent lytic breakdown of mitochondria in the large vacuoles which had become apparent 2 hours after administration of an NMDA antagonist.  After administration of 1.0 (mg/kg sc) MK-801 to rats, these neurotoxic changes became more apparent until about 12 hours post-dose, but the morphology of most cells appeared normal by light microscope about 24 hours post-dose.  With 10 (mg/kg sc) doses of MK-801, the vacuolation reaction was still visible by light microscope 48 hours post-dose.  After repeated doses of the NMDA antagonists MK-801 and PCP, the vacuolation reaction appeared consistent with the reaction after a single dose, so there was no evidence of a cumulative neurotoxic effect or that the reaction proceeded to an irreversible stage with repeated doses.  The lowest doses of ketamine and <a href=\"/wiki/Tiletamine\" title=\"Tiletamine\">tiletamine</a> that produced neurotoxic changes visible by light microscope 4 hours post dose were 40 (mg/kg sc) and 10 (mg/kg sc), respectively.  The potency of the drugs in producing these neurotoxic changes corresponded with their potency as NMDA antagonists: i.e. MK-801 &gt; PCP &gt; tiletamine &gt; ketamine.\n</p><p>Researcher <a href=\"/w/index.php?title=Roland_N._Auer&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Roland N. Auer (page does not exist)\">Roland N. Auer</a> conducted similar studies to look at the <a href=\"/wiki/Correlation\" class=\"mw-redirect\" title=\"Correlation\">correlation</a> between age and sex and the development of NMDA receptor antagonist neurotoxicity in test rats. Older rats experienced a much higher <a href=\"/wiki/Mortality_rate\" title=\"Mortality rate\">mortality rate</a> after the development of NAN. Female rats were found, at all ages, to have a higher incidence of <a href=\"/wiki/Necrotic\" class=\"mw-redirect\" title=\"Necrotic\">necrotic</a> (dead) <a href=\"/wiki/Neuron\" title=\"Neuron\">neurons</a> as a result of NAN.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p><a href=\"/wiki/Nitrous_oxide\" title=\"Nitrous oxide\">Nitrous oxide</a>, a common <a href=\"/wiki/Anesthetic\" title=\"Anesthetic\">anesthetic</a> for humans (especially in <a href=\"/wiki/Dentistry\" title=\"Dentistry\">dentistry</a>), has also been shown to cause <a href=\"/wiki/Vacuolization\" title=\"Vacuolization\">vacuolization</a> in rats' brains, but caused no irreversible lesions.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p><p><a href=\"/wiki/Dextromethorphan\" title=\"Dextromethorphan\">Dextromethorphan</a>, a common <a href=\"/wiki/Antitussive\" class=\"mw-redirect\" title=\"Antitussive\">antitussive</a> often found in <a href=\"/wiki/Cough_medicine\" title=\"Cough medicine\">cough medicines</a>, has been shown to cause vacuolization in rats' brains when administered at doses of 75&#160;mg/kg.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> However, oral administration of dextromethorphan hydrobromide (DXM HBr) to female rats in single doses as high as 120&#160;mg/kg did not result in detectable neurotoxic changes at 4\u20136 hours or 24\u201326 hours post-dose (female rats are more sensitive to NMDA antagonist neurotoxicity).<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>  The same researchers also found no evidence of neurotoxic changes in retrosplenial or cingulate cortices of male rats orally administered up to 400&#160;mg/(kg day) DXM HBr or female rats orally administered 120&#160;mg/(kg day) DXM HBr, both for 30 days.  Carliss et al. (2007) also found that rats administered 9&#160;mg/(kg day sc) (+)-MK-801 hydrogen maleate for 30 days did produce detectable vacuolation as expected.  When 30&#160;mg/(kg ip) <a href=\"/wiki/Dextrorphan\" title=\"Dextrorphan\">dextrorphan</a> was administered to male rats, neurotoxic changes were observed only 30 minutes post-dose.<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p><p>Even if the hypothesis of gross neural apoptosis proves to be false in humans, NMDA antagonists certainly have potential to permanently alter synaptic structure due to effects upon <a href=\"/wiki/Long_term_potentiation\" class=\"mw-redirect\" title=\"Long term potentiation\">long term potentiation</a>, which NMDA plays a crucial role in. Perhaps, with repeated usage, this would manifest, due to tolerance, thus downregulation, of the NMDA receptor system. This could feasibly alter the function/relationship of various structures, specifically the ventral visual stream, which is a likely cause of the anecdotal reports of <a href=\"/wiki/Hallucinogen_persisting_perception_disorder\" title=\"Hallucinogen persisting perception disorder\">hallucinogen persisting perception disorder</a> (HPPD) from such chronic users of novel psychoactive substances.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:No_original_research\" title=\"Wikipedia:No original research\"><span title=\"The material near this tag possibly contains original research. (October 2016)\">original research?</span></a></i>&#93;</sup>\n</p><p>In 2013 a study using magnetic resonance imaging showed brain lesions in ketamine addicts with severity depending on the duration of addiction and daily intake of ketamine. Cortical atrophy and holes in superficial white matter are seen early on. After 4 years of addiction lesions spread throughout the brain and damage is evident in the pons and other deeper brain structures.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> An autopsy study by <a href=\"/wiki/Johannes_Kornhuber\" title=\"Johannes Kornhuber\">Johannes Kornhuber</a> of 8 patients who had received <a href=\"/wiki/Amantadine\" title=\"Amantadine\">amantadine</a> therapy looked at the selectively vulnerable brain regions where Olney's lesions occur, the cingulate and retrosplenial cortex, and found no evidence of Olney's lesions.<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Prevention\">Prevention</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Olney%27s_lesions&amp;action=edit&amp;section=2\" title=\"Edit section: Prevention\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In medical settings, NMDA receptor antagonists are used as anesthetics, so <a href=\"/wiki/GABAA_receptor\" title=\"GABAA receptor\">GABA<sub>A</sub></a> receptor positive allosteric modulators are used to effectively prevent any <a href=\"/wiki/Neurotoxicity\" title=\"Neurotoxicity\">neurotoxicity</a> caused by them.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup>  Drugs that work to suppress NAN include <a href=\"/wiki/Anticholinergics\" class=\"mw-redirect\" title=\"Anticholinergics\">anticholinergics</a>,<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> <a href=\"/wiki/Benzodiazepines\" class=\"mw-redirect\" title=\"Benzodiazepines\">benzodiazepines</a>, <a href=\"/wiki/Barbiturates\" class=\"mw-redirect\" title=\"Barbiturates\">barbiturates</a><sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup> and <a href=\"/wiki/Agonists\" class=\"mw-redirect\" title=\"Agonists\">agonists</a> at the <a href=\"/wiki/Alpha-2_adrenergic_receptor\" title=\"Alpha-2 adrenergic receptor\">alpha-2 adrenergic receptor</a> in the brain, such as <a href=\"/wiki/Clonidine\" title=\"Clonidine\">clonidine</a>.\nConversely, coadministration of NMDA-antagonists with alpha-2 adrenergic <a href=\"/wiki/Receptor_antagonist\" title=\"Receptor antagonist\">antagonists</a>, like <a href=\"/wiki/Yohimbine\" title=\"Yohimbine\">yohimbine</a> could theoretically potentiate NAN.\n</p>\n<h2><span class=\"mw-headline\" id=\"Controversy\">Controversy</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Olney%27s_lesions&amp;action=edit&amp;section=3\" title=\"Edit section: Controversy\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>In Karl L. R. Jansen's book, <i>Ketamine: Dreams and Realities</i>, unpublished studies are cited on <a href=\"/wiki/Monkey\" title=\"Monkey\">monkey</a> brains. The opinion that DXM caused Olney's Lesions therefore came under fire. Jansen writes:\n</p>\n<table class=\"cquote pullquote\" role=\"presentation\" style=\"margin:auto; border-collapse: collapse; border: none; background-color: transparent; width: auto;\">\n<tbody><tr>\n<td style=\"width: 20px; vertical-align: top; border: none; color: #B2B7F2; font-size: 40px; font-family: &#39;Times New Roman&#39;, Times, serif; font-weight: bold; line-height: .6em; text-align: left; padding: 10px 10px;\">\u201c\n</td>\n<td style=\"vertical-align: top; border: none; padding: 4px 10px;\"><a href=\"/w/index.php?title=Roland_Auer&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Roland Auer (page does not exist)\">Roland Auer</a> injected the <a href=\"/wiki/Common_squirrel_monkey\" title=\"Common squirrel monkey\">common squirrel monkey</a> with <a href=\"/wiki/Dizocilpine\" title=\"Dizocilpine\">Dizocilpine</a>, or MK-801 and was unable to produce any vacuoles<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup>.\n<p>The brain regions where Olney's lesions occur show hypermetabolism <sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> [R]ats have rates of brain <a href=\"/wiki/Metabolism\" title=\"Metabolism\">metabolism</a> that are almost twice as high as those in humans to start with.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> It is because of this higher basal rate of cerebral metabolism that lesions may appear in rodents but not in large, mature primate brains. Ketamine causes over-excitement and euphoria in rats at doses below those at which it activates shutdown systems.\n</p><p>Frank Sharp also works in this area. I discussed with Sharp how this issue stood in 1998. His view was that reversible <a href=\"/wiki/Toxic\" class=\"mw-redirect\" title=\"Toxic\">toxic</a> changes in the rat started to appear at 40mg/kg and reached a level at which no further changes occurred (a plateau) at 100mg/kg, when a little cell death could be seen - but matters would not progress beyond this point. Extensive attempts to produce toxic changes in monkeys had been a total failure at doses up to 10mg/kg i.m. These Gorilla studies are unpublished. \n</p><p>I sought the view of Olney's colleague, Dr Nuri Farber. The work of his team indicated that N-P receptors must be blocked for at least 2 hours to cause reversible changes, and at least 24 hours to produce some cell death, in rats.\n[...][H]e thought that the methods used in monkey studies so far were unsatisfactory, because the animals were probably too young. Only adult rats show the toxic changes. He was not prepared to accept a clean bill of health for the drug in <a href=\"/wiki/Primate\" title=\"Primate\">primates</a> until this work with elderly Gorillas had been done, and until the <a href=\"/wiki/Drug_company\" class=\"mw-redirect\" title=\"Drug company\">drug companies</a> published their Gorilla studies to support their claims of harmlessness.\n</p><p>There is thus no published evidence at this time (January 2000) that ketamine can produce toxic cell changes in monkeys. The unpublished monkey data that we know about, that of Frank Sharp, actually shows that there is no damage at doses up to 10mg/kg.\n</p>\n</td>\n<td style=\"width: 20px; vertical-align: bottom; border: none; color: #B2B7F2; font-size: 40px; font-family: &#39;Times New Roman&#39;, Times, serif; font-weight: bold; line-height: .6em; text-align: right; padding: 10px 10px;\">\u201d\n</td></tr>\n<tr>\n<td colspan=\"3\" class=\"cquotecite\" style=\"border: none; padding-right: 4%; font-size: smaller; line-height:normal; text-align: right;\"><cite>\u2014&#8201;Karl Jansen, <i>Ketamine: Dreams and Realities</i> (2004)<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup></cite>\n</td></tr></tbody></table>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Olney%27s_lesions&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div role=\"navigation\" aria-label=\"Portals\" class=\"noprint portal plainlist tright\" style=\"margin:0.5em 0 0.5em 1em;border:solid #aaa 1px\">\n<ul style=\"display:table;box-sizing:border-box;padding:0.1em;max-width:175px;background:#f9f9f9;font-size:85%;line-height:110%;font-style:italic;font-weight:bold\">\n<li style=\"display:table-row\"><span style=\"display:table-cell;padding:0.2em;vertical-align:middle;text-align:center\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Neuro_logo.png/32px-Neuro_logo.png\" width=\"32\" height=\"26\" class=\"noviewer\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Neuro_logo.png/48px-Neuro_logo.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Neuro_logo.png/64px-Neuro_logo.png 2x\" data-file-width=\"75\" data-file-height=\"62\" /></span><span style=\"display:table-cell;padding:0.2em 0.2em 0.2em 0.3em;vertical-align:middle\"><a href=\"/wiki/Portal:Neuroscience\" title=\"Portal:Neuroscience\">Neuroscience portal</a></span></li></ul></div>\n<ul><li><a href=\"/wiki/NMDA_receptor\" title=\"NMDA receptor\">NMDA receptor</a></li>\n<li><a href=\"/wiki/NMDA_receptor_antagonist\" title=\"NMDA receptor antagonist\">NMDA receptor antagonist</a></li>\n<li><a href=\"/wiki/Dissociative\" title=\"Dissociative\">Dissociative</a></li>\n<li><a href=\"/wiki/Neurotoxic_drug\" class=\"mw-redirect\" title=\"Neurotoxic drug\">Neurotoxic drug</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Olney%27s_lesions&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-olney-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-olney_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Olney J, Labruyere J, Price M (1989). \"Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs\". <i>Science</i>. <b>244</b> (4910): 1360\u20132. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.2660263\">10.1126/science.2660263</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2660263\">2660263</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Pathological+changes+induced+in+cerebrocortical+neurons+by+phencyclidine+and+related+drugs&amp;rft.volume=244&amp;rft.issue=4910&amp;rft.pages=1360-2&amp;rft.date=1989&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.2660263&amp;rft_id=info%3Apmid%2F2660263&amp;rft.aulast=Olney&amp;rft.aufirst=J&amp;rft.au=Labruyere%2C+J&amp;rft.au=Price%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\">Olney JW, Labruyere J, Price MT. (1989) Pathological Changes Induced in Cerebrocortical Neurons by Phencyclidine and Related Drugs. <i>Science</i>.  244: 1360 - 1362. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2660263\">2660263</a></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Auer RN (1996). \"Effect of age and sex on N-<a href=\"/wiki/Methyl\" class=\"mw-redirect\" title=\"Methyl\">methyl</a>-D-<a href=\"/wiki/Aspartate\" class=\"mw-redirect\" title=\"Aspartate\">aspartate</a> antagonist-induced <a href=\"/wiki/Neuronal\" class=\"mw-redirect\" title=\"Neuronal\">neuronal</a> <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrosis</a> in rats\". <i>Stroke</i>. <b>27</b> (4): 743\u2013746. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/01.str.27.4.743\">10.1161/01.str.27.4.743</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8614941\">8614941</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Stroke&amp;rft.atitle=Effect+of+age+and+sex+on+N-methyl-D-aspartate+antagonist-induced+neuronal+necrosis+in+rats&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=743-746&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1161%2F01.str.27.4.743&amp;rft_id=info%3Apmid%2F8614941&amp;rft.au=Auer+RN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jevtovic-Todorovic V, Beals J, Benshoff N, Olney J (2003). \"Prolonged exposure to inhalational <a href=\"/wiki/Anesthetic\" title=\"Anesthetic\">anesthetic</a> <a href=\"/wiki/Nitrous_oxide\" title=\"Nitrous oxide\">nitrous oxide</a> kills <a href=\"/wiki/Neuron\" title=\"Neuron\">neurons</a> in adult rat brain\". <i>Neuroscience</i>. <b>122</b> (3): 609\u201316. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.neuroscience.2003.07.012\">10.1016/j.neuroscience.2003.07.012</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14622904\">14622904</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Neuroscience&amp;rft.atitle=Prolonged+exposure+to+inhalational+anesthetic+nitrous+oxide+kills+neurons+in+adult+rat+brain&amp;rft.volume=122&amp;rft.issue=3&amp;rft.pages=609-16&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuroscience.2003.07.012&amp;rft_id=info%3Apmid%2F14622904&amp;rft.aulast=Jevtovic-Todorovic&amp;rft.aufirst=V&amp;rft.au=Beals%2C+J&amp;rft.au=Benshoff%2C+N&amp;rft.au=Olney%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hashimoto, K; Tomitaka, S; Narita, N; Minabe, Y; Iyo, M; Fukui, S (1996). \"<a href=\"/wiki/Heat_shock_protein\" title=\"Heat shock protein\">heat shock protein</a> <a href=\"/wiki/Hsp70\" title=\"Hsp70\">Hsp70</a> in rat <a href=\"/w/index.php?title=Retrosplenial&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Retrosplenial (page does not exist)\">retrosplenial</a> <a href=\"/wiki/Cerebral_cortex\" title=\"Cerebral cortex\">cortex</a>\". <i>Environmental Toxicology and Pharmacology</i>. <b>1</b> (4): 235\u2013239. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/1382-6689%2896%2900016-6\">10.1016/1382-6689(96)00016-6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21781688\">21781688</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Environmental+Toxicology+and+Pharmacology&amp;rft.atitle=Induction+of+heat+shock+protein+Hsp70+in+rat+retrosplenial+cortex+following+administration+of+dextromethorphan&amp;rft.volume=1&amp;rft.issue=4&amp;rft.pages=235-239&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1016%2F1382-6689%2896%2900016-6&amp;rft_id=info%3Apmid%2F21781688&amp;rft.au=Hashimoto%2C+K&amp;rft.au=Tomitaka%2C+S&amp;rft.au=Narita%2C+N&amp;rft.au=Minabe%2C+Y&amp;rft.au=Iyo%2C+M&amp;rft.au=Fukui%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Carliss RD, Radovsky A, Chengelis CP, O'neill TP, Shuey DL (2007). \"Oral administration of dextromethorphan does not produce neuronal vacuolation in the rat brain\". <i>NeuroToxicology</i>. <b>28</b> (4): 813\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.neuro.2007.03.009\">10.1016/j.neuro.2007.03.009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17573115\">17573115</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=NeuroToxicology&amp;rft.atitle=Oral+administration+of+dextromethorphan+does+not+produce+neuronal+vacuolation+in+the+rat+brain&amp;rft.volume=28&amp;rft.issue=4&amp;rft.pages=813-8&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.1016%2Fj.neuro.2007.03.009&amp;rft_id=info%3Apmid%2F17573115&amp;rft.aulast=Carliss&amp;rft.aufirst=RD&amp;rft.au=Radovsky%2C+A&amp;rft.au=Chengelis%2C+CP&amp;rft.au=O%27neill%2C+TP&amp;rft.au=Shuey%2C+DL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\">Ortiz GG, Guerrero JM, Reiter RJ, Poeggeler BH, Bitzer-Quintero OK, Feria-Velasco A. (1999) Neurotoxicity of dextrorphan.  Arch Med Res.  30: 125 - 127. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10372446\">10372446</a></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F (2017). \"The \"Endless Trip\" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review\". <i>Frontiers in Psychiatry</i>. <b>8</b>: 1\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3389/fpsyt.2017.00240\">10.3389/fpsyt.2017.00240</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/29209235\">29209235</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Psychiatry&amp;rft.atitle=The+%E2%80%9CEndless+Trip%E2%80%9D+among+the+NPS+Users%3A+Psychopathology+and+Psychopharmacology+in+the+Hallucinogen-Persisting+Perception+Disorder.+A+Systematic+Review&amp;rft.volume=8&amp;rft.pages=1-10&amp;rft.date=2017&amp;rft_id=info%3Adoi%2F10.3389%2Ffpsyt.2017.00240&amp;rft_id=info%3Apmid%2F29209235&amp;rft.aulast=Orsolini&amp;rft.aufirst=L&amp;rft.au=Papanti%2C+GD&amp;rft.au=De+Berardis%2C+D&amp;rft.au=Guirguis%2C+A&amp;rft.au=Corkery%2C+JM&amp;rft.au=Schifano%2C+F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wang C, Zheng D, Xu J, Lam W, Yew DT (2013). \"Brain damages in ketamine addicts as revealed by magnetic resonance imaging\". <i>Frontiers in Neuroanatomy</i>. <b>7</b> (23). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3389/fnana.2013.00023\">10.3389/fnana.2013.00023</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Neuroanatomy&amp;rft.atitle=Brain+damages+in+ketamine+addicts+as+revealed+by+magnetic+resonance+imaging&amp;rft.volume=7&amp;rft.issue=23&amp;rft.date=2013&amp;rft_id=info%3Adoi%2F10.3389%2Ffnana.2013.00023&amp;rft.aulast=Wang&amp;rft.aufirst=C&amp;rft.au=Zheng%2C+D&amp;rft.au=Xu%2C+J&amp;rft.au=Lam%2C+W&amp;rft.au=Yew%2C+DT&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kornhuber J, Jellinger K, Wiltfang J, Leblhuber F, Riederer P (1999). \"The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissue\". <i>Acta Neuropathologica</i>. <b>98</b>: 85\u201390. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10412804\">10412804</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Acta+Neuropathologica&amp;rft.atitle=The+N-methyl-D-aspartate+receptor+channel+blocker+amantadine+does+not+cause+histopathological+alterations+in+human+brain+tissue&amp;rft.volume=98&amp;rft.pages=85-90&amp;rft.date=1999&amp;rft_id=info%3Apmid%2F10412804&amp;rft.aulast=Kornhuber&amp;rft.aufirst=J&amp;rft.au=Jellinger%2C+K&amp;rft.au=Wiltfang%2C+J&amp;rft.au=Leblhuber%2C+F&amp;rft.au=Riederer%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Nakao S, Nagata A, Masuzawa M, Miyamoto E, Yamada M, Nishizawa N, Shingu K (2003). \"[NMDA receptor antagonist neurotoxicity and psychotomimetic activity]\". <i>Masui</i>. <b>52</b> (6): 594\u2013602. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12854473\">12854473</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Masui&amp;rft.atitle=%5BNMDA+receptor+antagonist+neurotoxicity+and+psychotomimetic+activity%5D&amp;rft.volume=52&amp;rft.issue=6&amp;rft.pages=594-602&amp;rft.date=2003&amp;rft_id=info%3Apmid%2F12854473&amp;rft.aulast=Nakao&amp;rft.aufirst=S&amp;rft.au=Nagata%2C+A&amp;rft.au=Masuzawa%2C+M&amp;rft.au=Miyamoto%2C+E&amp;rft.au=Yamada%2C+M&amp;rft.au=Nishizawa%2C+N&amp;rft.au=Shingu%2C+K&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.lycaeum.org/drugs/Cyclohexamines/nmda-toxicity.html\">[D.Wozniak - NMDA Antagonist Neurotoxicity: Mechanism and Prevention]</a></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Olney J, Labruyere J, Wang G, Wozniak D, Price M, Sesma M (1991). \"NMDA antagonist neurotoxicity: mechanism and prevention\". <i>Science</i>. <b>254</b> (5037): 1515\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1835799\">10.1126/science.1835799</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1835799\">1835799</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=NMDA+antagonist+neurotoxicity%3A+mechanism+and+prevention&amp;rft.volume=254&amp;rft.issue=5037&amp;rft.pages=1515-8&amp;rft.date=1991&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1835799&amp;rft_id=info%3Apmid%2F1835799&amp;rft.aulast=Olney&amp;rft.aufirst=J&amp;rft.au=Labruyere%2C+J&amp;rft.au=Wang%2C+G&amp;rft.au=Wozniak%2C+D&amp;rft.au=Price%2C+M&amp;rft.au=Sesma%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Auer RN, Coupland SG, Jason GW, Archer DP, Payne J, Belzberg AJ, Ohtaki M, Tranmer BI (1996). \"Postischemic therapy with MK-801 (<a href=\"/wiki/Dizocilpine\" title=\"Dizocilpine\">dizocilpine</a>) in a primate model of transient focal brain ischemia\". <i>Molecular and Chemical Neuropathology</i>. <b>29</b> (2-3): 193\u2013210. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/BF02815002\">10.1007/BF02815002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8971696\">8971696</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+and+Chemical+Neuropathology&amp;rft.atitle=Postischemic+therapy+with+MK-801+%28dizocilpine%29+in+a+primate+model+of+transient+focal+brain+ischemia&amp;rft.volume=29&amp;rft.issue=2-3&amp;rft.pages=193-210&amp;rft.date=1996&amp;rft_id=info%3Adoi%2F10.1007%2FBF02815002&amp;rft_id=info%3Apmid%2F8971696&amp;rft.aulast=Auer&amp;rft.aufirst=RN&amp;rft.au=Coupland%2C+SG&amp;rft.au=Jason%2C+GW&amp;rft.au=Archer%2C+DP&amp;rft.au=Payne%2C+J&amp;rft.au=Belzberg%2C+AJ&amp;rft.au=Ohtaki%2C+M&amp;rft.au=Tranmer%2C+BI&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kurumaji A, McCulloch J (1989). \"Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane\". <i>Journal of Cerebral Blood Flow and Metabolism</i>. <b>9</b>: 786\u2013794. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/jcbfm.1989.112\">10.1038/jcbfm.1989.112</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/2684992\">2684992</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cerebral+Blood+Flow+and+Metabolism&amp;rft.atitle=Effects+of+MK-801+upon+local+cerebral+glucose+utilisation+in+conscious+rats+and+in+rats+anaesthetised+with+halothane&amp;rft.volume=9&amp;rft.pages=786-794&amp;rft.date=1989&amp;rft_id=info%3Adoi%2F10.1038%2Fjcbfm.1989.112&amp;rft_id=info%3Apmid%2F2684992&amp;rft.aulast=Kurumaji&amp;rft.aufirst=A&amp;rft.au=McCulloch%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Blin J, Ray CA, Chase TN, Piercey MF. \"Regional cerebral glucose metabolism compared in rodents and humans\". <i>Brain Research</i>. <b>568</b>: 215\u2013222. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1814569\">1814569</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Brain+Research&amp;rft.atitle=Regional+cerebral+glucose+metabolism+compared+in+rodents+and+humans&amp;rft.volume=568&amp;rft.pages=215-222&amp;rft_id=info%3Apmid%2F1814569&amp;rft.aulast=Blin&amp;rft.aufirst=J&amp;rft.au=Ray%2C+CA&amp;rft.au=Chase%2C+TN&amp;rft.au=Piercey%2C+MF&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AOlney%27s+lesions\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\">Jansen, Karl. <i>Ketamine: Dreams and Realities</i>. MAPS, 2004. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-9660019-7-4\" title=\"Special:BookSources/0-9660019-7-4\">0-9660019-7-4</a></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Olney%27s_lesions&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://leda.lycaeum.org/?ID=13066\">\"Lycaeum\" about NAN</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2225\nCached time: 20180921205953\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.264 seconds\nReal time usage: 0.330 seconds\nPreprocessor visited node count: 1383/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 34854/2097152 bytes\nTemplate argument size: 3631/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 19349/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.132/10.000 seconds\nLua memory usage: 4.01 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  280.787      1 -total\n 70.04%  196.675      1 Template:Reflist\n 44.28%  124.329     13 Template:Cite_journal\n 22.06%   61.952      1 Template:Or\n 14.95%   41.975      1 Template:Fix\n  9.31%   26.152      1 Template:Category_handler\n  8.04%   22.565      1 Template:ISBN\n  7.70%   21.631      2 Template:PMID\n  7.38%   20.730      3 Template:Catalog_lookup_link\n  4.57%   12.834      1 Template:Delink\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1443167-0!canonical and timestamp 20180921205952 and revision id 859902241\n -->\n</div>"},"langlinks":[{"lang":"de","url":"https://de.wikipedia.org/wiki/John_W._Olney","langname":"German","autonym":"Deutsch","*":"John W. Olney"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Lesiones_de_Olney","langname":"Spanish","autonym":"espa\u00f1ol","*":"Lesiones de Olney"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Lesioni_di_Olney","langname":"Italian","autonym":"italiano","*":"Lesioni di Olney"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E3%82%AA%E3%83%AB%E3%83%8B%E3%83%BC%E3%81%AE%E7%97%85%E5%A4%89","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u30aa\u30eb\u30cb\u30fc\u306e\u75c5\u5909"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Les%C3%B5es_de_Olney","langname":"Portuguese","autonym":"portugu\u00eas","*":"Les\u00f5es de Olney"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B9%D1%80%D0%BE%D1%82%D0%BE%D0%BA%D1%81%D0%B8%D1%87%D0%BD%D0%BE%D1%81%D1%82%D1%8C_NMDA-%D0%B0%D0%BD%D1%82%D0%B0%D0%B3%D0%BE%D0%BD%D0%B8%D1%81%D1%82%D0%BE%D0%B2","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u041d\u0435\u0439\u0440\u043e\u0442\u043e\u043a\u0441\u0438\u0447\u043d\u043e\u0441\u0442\u044c NMDA-\u0430\u043d\u0442\u0430\u0433\u043e\u043d\u0438\u0441\u0442\u043e\u0432"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Olneyn_leesiot","langname":"Finnish","autonym":"suomi","*":"Olneyn leesiot"}],"categories":[{"sortkey":"Olney's Lesions","hidden":"","*":"All_articles_that_may_contain_original_research"},{"sortkey":"Olney's Lesions","hidden":"","*":"Articles_that_may_contain_original_research_from_October_2016"},{"sortkey":"Olney's Lesions","hidden":"","*":"Articles_with_attributed_pull_quotes"},{"sortkey":"Olney's Lesions","*":"Neurotrauma"},{"sortkey":"Olney's Lesions","*":"Toxicology"},{"sortkey":"Olney's Lesions","*":"Lesion"}],"links":[{"ns":14,"exists":"","*":"Category:Articles that may contain original research from October 2016"},{"ns":0,"exists":"","*":"Agonists"},{"ns":0,"exists":"","*":"Alpha-2 adrenergic receptor"},{"ns":0,"exists":"","*":"Alzheimer's disease"},{"ns":0,"exists":"","*":"Amantadine"},{"ns":0,"exists":"","*":"Anesthesia"},{"ns":0,"exists":"","*":"Anesthetic"},{"ns":0,"exists":"","*":"Anticholinergics"},{"ns":0,"exists":"","*":"Antitussive"},{"ns":0,"exists":"","*":"Aspartate"},{"ns":0,"exists":"","*":"Barbiturates"},{"ns":0,"exists":"","*":"Benzodiazepines"},{"ns":0,"exists":"","*":"Brain damage"},{"ns":0,"exists":"","*":"Cerebral cortex"},{"ns":0,"exists":"","*":"Clonidine"},{"ns":0,"exists":"","*":"Common squirrel monkey"},{"ns":0,"exists":"","*":"Correlation"},{"ns":0,"exists":"","*":"Cough medicine"},{"ns":0,"exists":"","*":"Dentistry"},{"ns":0,"exists":"","*":"Dextromethorphan"},{"ns":0,"exists":"","*":"Dextrorphan"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dissociative"},{"ns":0,"exists":"","*":"Dizocilpine"},{"ns":0,"exists":"","*":"Drug company"},{"ns":0,"exists":"","*":"GABAA receptor"},{"ns":0,"exists":"","*":"Hallucinogen persisting perception disorder"},{"ns":0,"exists":"","*":"Heat shock protein"},{"ns":0,"exists":"","*":"Hsp70"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Johannes Kornhuber"},{"ns":0,"exists":"","*":"John Olney"},{"ns":0,"exists":"","*":"Ketamine"},{"ns":0,"exists":"","*":"Long term potentiation"},{"ns":0,"exists":"","*":"MK-801"},{"ns":0,"exists":"","*":"Memantine"},{"ns":0,"exists":"","*":"Metabolism"},{"ns":0,"exists":"","*":"Methyl"},{"ns":0,"exists":"","*":"Monkey"},{"ns":0,"exists":"","*":"Mortality rate"},{"ns":0,"exists":"","*":"NMDA receptor"},{"ns":0,"exists":"","*":"NMDA receptor antagonist"},{"ns":0,"exists":"","*":"Necrosis"},{"ns":0,"exists":"","*":"Necrotic"},{"ns":0,"exists":"","*":"Neuron"},{"ns":0,"exists":"","*":"Neuronal"},{"ns":0,"exists":"","*":"Neurotoxic drug"},{"ns":0,"exists":"","*":"Neurotoxicity"},{"ns":0,"exists":"","*":"Neurotoxin"},{"ns":0,"exists":"","*":"Nitrous oxide"},{"ns":0,"exists":"","*":"Parkinson's disease"},{"ns":0,"exists":"","*":"Patient safety"},{"ns":0,"exists":"","*":"Pharmacotherapy"},{"ns":0,"exists":"","*":"Phencyclidine"},{"ns":0,"exists":"","*":"Primate"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Receptor antagonist"},{"ns":0,"exists":"","*":"Tiletamine"},{"ns":0,"exists":"","*":"Toxic"},{"ns":0,"exists":"","*":"Vacuolation"},{"ns":0,"exists":"","*":"Vacuolization"},{"ns":0,"exists":"","*":"Yohimbine"},{"ns":0,"*":"Retrosplenial"},{"ns":0,"*":"Roland N. Auer"},{"ns":0,"*":"Roland Auer"},{"ns":4,"exists":"","*":"Wikipedia:No original research"},{"ns":100,"exists":"","*":"Portal:Neuroscience"}],"templates":[{"ns":10,"exists":"","*":"Template:Or"},{"ns":10,"exists":"","*":"Template:Original research inline"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Cquote"},{"ns":10,"exists":"","*":"Template:Portal"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:PMID"},{"ns":10,"exists":"","*":"Template:Catalog lookup link"},{"ns":10,"exists":"","*":"Template:Trim"},{"ns":10,"exists":"","*":"Template:Yesno-no"},{"ns":10,"exists":"","*":"Template:Yesno"},{"ns":10,"exists":"","*":"Template:ISBN"},{"ns":10,"exists":"","*":"Template:Error-small"},{"ns":10,"exists":"","*":"Template:Tl"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Portal"},{"ns":828,"exists":"","*":"Module:Portal/images/n"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check isxn"},{"ns":828,"exists":"","*":"Module:Error"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Neuro_logo.png"],"externallinks":["//doi.org/10.1126/science.2660263","//www.ncbi.nlm.nih.gov/pubmed/2660263","//doi.org/10.1161/01.str.27.4.743","//www.ncbi.nlm.nih.gov/pubmed/8614941","//doi.org/10.1016/j.neuroscience.2003.07.012","//www.ncbi.nlm.nih.gov/pubmed/14622904","//doi.org/10.1016/1382-6689(96)00016-6","//www.ncbi.nlm.nih.gov/pubmed/21781688","//doi.org/10.1016/j.neuro.2007.03.009","//www.ncbi.nlm.nih.gov/pubmed/17573115","//www.ncbi.nlm.nih.gov/pubmed/10372446","//doi.org/10.3389/fpsyt.2017.00240","//www.ncbi.nlm.nih.gov/pubmed/29209235","//doi.org/10.3389/fnana.2013.00023","//www.ncbi.nlm.nih.gov/pubmed/10412804","//www.ncbi.nlm.nih.gov/pubmed/12854473","http://www.lycaeum.org/drugs/Cyclohexamines/nmda-toxicity.html","//doi.org/10.1126/science.1835799","//www.ncbi.nlm.nih.gov/pubmed/1835799","//doi.org/10.1007/BF02815002","//www.ncbi.nlm.nih.gov/pubmed/8971696","//doi.org/10.1038/jcbfm.1989.112","//www.ncbi.nlm.nih.gov/pubmed/2684992","//www.ncbi.nlm.nih.gov/pubmed/1814569","http://leda.lycaeum.org/?ID=13066"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Olney's_lesions","byteoffset":1709,"anchor":"History"},{"toclevel":1,"level":"2","line":"Prevention","number":"2","index":"2","fromtitle":"Olney's_lesions","byteoffset":8750,"anchor":"Prevention"},{"toclevel":1,"level":"2","line":"Controversy","number":"3","index":"3","fromtitle":"Olney's_lesions","byteoffset":10040,"anchor":"Controversy"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"4","fromtitle":"Olney's_lesions","byteoffset":13449,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Olney's_lesions","byteoffset":13579,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"Olney's_lesions","byteoffset":13607,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Olney's lesions","iwlinks":[],"properties":[{"name":"defaultsort","*":"Olney's Lesions"},{"name":"wikibase_item","*":"Q2657006"}]}}